A Genetic Substudy Associated With the Avastin (Bevacizumab) Study MO19390 in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. - Contacts and Locations

A Genetic Substudy Associated With the Avastin (Bevacizumab) Study MO19390 in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.

This study is ongoing, but not recruiting participants.

Study NCT00642824. Last updated on October 15, 2008. Information provided by Hoffmann-La Roche

Please refer to this study by its ClinicalTrials.gov identifier: NCT00642824

Locations


Spain

	VALENCIA, Spain, 46009

	MURCIA, Spain, 30008

	MADRID, Spain, 28040

	MADRID, Spain, 28046

	BARAKALDO, Spain, 48903

	ZARAGOZA, Spain, 50009

	HUESCA, Spain, 22004

	PAMPLONA, Spain, 31008

	GIRONA, Spain, 17007

	VALENCIA, Spain, 41014

	BADALONA, Spain, 08915

	LA LAGUNA, Spain, 38320

	LUGO, Spain, 27004

	ALICANTE, Spain, 03010

	LAS PALMAS DE GRAN CANARIA, Spain, 35016

	MADRID, Spain, 28002

	SALAMANCA, Spain, 37007

	ALCORCON, Spain, 28922

	PALMA DE MALLORCA, Spain, 07014

Sponsors and Collaborators

Hoffmann-La Roche

Investigators


Study Director:	Clinical Trials	Hoffmann-La Roche, +1 973 235 5000